Recent Quotes (30 days)

You have no recent quotes
chg | %

Covidien Ltd news

   Watch this stock
Showing stories 1 - 10 of about 71   

Articles published

COV 106.71 0.00 (0.00%)
price chart
Medtronic: the tax inversion that got away
It was the tax inversion that got away. Medtronic, one of the world's biggest medical technology companies, has completed its $49.9bn takeover of Ireland-based Covidien, and shares in the combined company started trading on the New York Stock Exchange ...
Medtronic Completes Covidien Acquisition for $50B
Moody's downgrades Medtronic's ratings to A3 from A2; outlook negative (press release) (subscription)
The Tax-Shopping Backstory of the Medtronic-Covidien Inversion
A new regime spun off Tyco's health care unit into a separate publicly traded firm, Covidien Ltd., also headquartered in Bermuda.
Medtronic snaps up Covidien for $42.9bn  Financial Times
Medtronic agrees to buy Covidien for $42.9b in cash, stock  Boston Globe
Related articles »  
Global Pancreatic Stent Market 2017 – Boston Scientific Corporation, Covidien ...
The latest report Pancreatic Stent Market by QY Research added to it's database and brings to light the comprehensive study and factual information of global market.
Ethicon, 3M, Covidien And Various Local Manufacturers Compete In Growing ...
3M India Limited has R&D centers in Bengaluru and Gurgaon and manufacturing facilities in Bengaluru, Pune and Ahmedabad.
Medtronic sells supplies unit to Cardinal Health for $6.1bn
Medtronic is shedding assets following the completion of its almost $50bn acquisition of Ireland's Covidien in 2015. The deal was one of the last major “inversions”, which allowed the company to reduce its US tax bill by moving its legal headquarters ...
Somewhat Favorable Media Coverage Somewhat Unlikely to Affect Covidien (COV ...
Receive News & Ratings for Covidien Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covidien Ltd and related companies with's FREE daily email newsletter.
The Federal Circuit Weighs in on the Doctrine of Equivalents for Chemical ...
It was developed and sold under a New Drug Application by Covidien Ltd. (“Covidien”) under the name Lymphazurin�.[2] Covidien was the sole supplier for over 30 years, but had supply problems throughout the early 2000s, and wound up developing its ...
Chesterfield council receives masterplan for nearly 600 new homes
During World War One, Staveley Coal and Iron Company Ltd developed its chemical operations and a factory was on the site until 2012 when American owners Covidien announced the closure of the plant. Other major developments in the borough include ...
Bionik Laboratories Appoints Malcolm G. Bock as Vice President of Engineering
Prior to that, Mr. Bock served as the Senior Director of Global R&D for Covidien Ltd., a spin-off of Tyco International, where he was responsible for R&D and launching 15 new products, including both durable electro-mechanical systems and single-use ...
Medtronic to sell medical-supplies business
In 2014 Medtronic acquired Covidien in a deal worth almost $50 billion. The sale could occur in a single deal or through the division of smaller chunks of the business.